400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / Epigenetic Reader Domain / MAK683
CAS No.: 1951408-58-4
Synonyms: EED inhibitor-1
An inhibitor of embryonic ectoderm development protein (EED) and allosteric inhibitor of polycomb repressive complex 2 (PRC2), with potential antineoplastic activity.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02900651 | Diffuse Large B-cell Lymphoma | Phase 1 Phase 2 | Recruiting | August 5, 2019 | United States, California ... more >> Novartis Investigative Site Recruiting San Francisco, California, United States, 94115 Novartis Investigative Site Recruiting Santa Monica, California, United States, 90404 Contact: Ruth M. Gonzalez Rngonzalez@mednet.ucla.edu Principal Investigator: Zev A. Wainberg United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Anna Lui 713-563-4667 alui@mdanderson.org Principal Investigator: Vivek Subbiah Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Recruiting Koeln, Germany, 50937 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Japan Novartis Investigative Site Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28041 Collapse << |
实验方案
技术信息
CAS号 | 1951408-58-4 | 储存条件 |
|
|
分子式 | C20H17FN6O | 运输 | 蓝冰 | |
分子量 | 376.39 | 别名 | EED inhibitor-1 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02900651 | Diffuse Large B-cell Lymphoma | Phase 1 Phase 2 | Recruiting | August 5, 2019 | United States, California ... more >> Novartis Investigative Site Recruiting San Francisco, California, United States, 94115 Novartis Investigative Site Recruiting Santa Monica, California, United States, 90404 Contact: Ruth M. Gonzalez Rngonzalez@mednet.ucla.edu Principal Investigator: Zev A. Wainberg United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Anna Lui 713-563-4667 alui@mdanderson.org Principal Investigator: Vivek Subbiah Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Recruiting Koeln, Germany, 50937 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Japan Novartis Investigative Site Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28041 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网